A Prospective, Multi-center Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Element™)
NCT00824434
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Atherosclerosis
Coronary Artery Disease
Interventions
DEVICE:
PROMUS Element™
Sponsor
Boston Scientific Corporation